GENE ONLINE|News &
Opinion
Blog

Joy Lin

Without knowledge, there is no imagination. Without imagination, knowledge is meaningless

WRITTEN BY Joy Lin

Seagen, Genmab’s Antibody Drug Conjugate Bags FDA Approval for Cervical Cancer
2021-09-22
FDA Accepts BeiGene’s BLA for Esophageal Cancer Drug
2021-09-14
Samsung Bioepis Presents 5-Year Follow-up Results on Trastuzumab Biosimilar at ESMO 2021
2021-09-13
Roche to Acquire Long-Time Partner to Advance Molecular Diagnostics for Infectious Diseases
2021-09-10
AM-Pharma Partners with Kyowa Kirin in $289m Deal for Kidney Drug
2021-09-09
JW Therapeutics’ CAR-T Approval in China Comes On the Heels of its Rival
2021-09-08
Cancer Fears Puts BioMarin’s Phearless Study on Hold
2021-09-07
Oxford Nanopore Gears Up for Highly-Anticipated LSE IPO
2021-09-03
Janssen’s Long-acting Schizophrenia Drug Notches FDA Approval
2021-09-02
J&J’s HIV Vaccine Results Disappoint, Trial Halted But Search Continues
2021-09-01
Revelation Goes the SPAC Way to list on Nasdaq
2021-08-31
Clarity Becomes ASX’s Biggest Ever Biotech IPO
2021-08-30
Gilead’s Kite Wins Legal Battle Against BMS, Gets Its $1.2B Fine Overturned
2021-08-27
Brii Bio’s COVID-19 Antibody Cocktail Sees Promising Results in Phase 3 ACTIV-2 Trial
2021-08-26
Roche Bets on Shape’s RNA Editing Tech in $3B Gene Therapy Collab
2021-08-25
1 22 23 24 25
Scroll to Top